2022 Best Cannabis Stocks to Invest In

As the legal cannabis industry within the United States grows and more states accept legalization, cannabis stocks also become increasingly popular. Stocks on their own can be overwhelming - putting cannabis into the mix, which is still federally illegal and unavailable on the major stock exchanges, can get even more complicated to navigate. What do you need to know about weed stock, and which ones are worth checking out? What's the newest cannabis stocks news? Here's what we know.

A Quick Overview of Cannabis Stocks

Because cannabis is still federally illegal in the United States, there are very few cannabis companies publicly traded on the stock market. Most cannabis stocks are over-the-counter stocks (OTC) traded via a broker-dealer network instead of on a centralized exchange. These OTCs promote equity and financial gains for many canna-businesses that otherwise wouldn't be available to investors. They are far less regulated and have no historical references, so the valuation of the company's stock can be very different from its actual worth. Unfortunately, this can work against the benefit of the investor and the company. Additionally, these OTCs offer considerably less exposure or revenue generation than major exchanges. 

Cannabis stocks are making quick ground, however. In 2018, The Cronos Group Inc. (NASDAQ - CRON), a medical cannabis producer, became the first state-legal cannabis company to be listed on any major U.S. exchange, let alone on the NASDAQ. Several others have been added to the exchange since then, and many have performed very well, including Canopy Growth on the New York Stock Exchange (NYSE). 

8 Cannabis Stocks in 2022 to Invest In

Unsplash

Now, in 2022, there are more stocks than ever to invest in, and we're confident that the numbers will only continue to grow from here out. Here's a cannabis stocks list that you should put some research into and potentially invest in if you have the chance! Please note that this is not official financial advice. 

Curaleaf Holdings Inc. (OTCMKTS - CURLF)

Stock Exchange: OTC Market Group

Cost per Stock: $7.49 USD

Growth in the Last Year: - $1.26 (-14.40%)

Lifetime Growth: - $0.94 (-11.15%)

Date Added to Exchange: November 2018

Curaleaf Holdings deals with the production and distribution of cannabis across 23 different states. They have 101 dispensaries, 22 cultivation sites, 30 processing sites, and over 350,000 registered patients, but their year-over-year numbers aren't indicative of their overall growth. The company's five-year average sales growth is over 200%, meaning Curaleaf stock in 2022 should perform well. 

Trulieve Cannabis Corp. (OTCMKTS - TCNNF)

Stock Exchange: OTC Market Group

Cost per Stock: $21.57 USD

Growth in the Last Year: - $5.14 (-19.24%)

Lifetime Growth: $9.89 (84.67%)

Date Added to Exchange: September 2018

This vertically integrated multi-state operator has over 110 dispensaries in California and another 50 across the United States. They control all aspects of the seed-to-sale process and have had three consecutive years of profitability. They're also acquiring MSO Harvest Health & Recreation, which should give Trulieve a leg up in the new recreational Arizona market and give you another reason to research Trulieve stock.

GrowGeneration Corp. (NASDAQ - GRWG)

Stock Exchange: NASDAQ

Cost per Stock: $8.30 USD

Growth in the Last Year: - $5.50 (-39.83%)

Lifetime Growth: $6.01 (261.30%)

Date Added to Exchange: November 2016

This hydroponic and aquaponic equipment retailer may not be a state-legal cannabis company, but many of its products are used for cannabis cultivation. Because of two recent multi-million dollar acquisitions, their status as one of the largest hydroponic suppliers in the country gives them leverage in a market that continues to grow as more states legalize cannabis. GrowGeneration's stock didn't perform well over the last year, so there's plenty of room to bounce back for shareholder profits.

Village Farms International Inc. (NASDAQ - VFF)

Stock Exchange: NASDAQ

Cost per Stock: $5.13 USD

Growth in the Last Year: - $1.55 (-23.20%)

Lifetime Growth: $3.86 (303.94%)

Date Added to Exchange: May 2012

Village Farms International has been around for a while - and as one of the longest-running cannabis companies to be publicly traded, they have a long track record of steady growth (save this last year, which was difficult for most industries). They are a vertically integrated greenhouse grower whose products include produce, cannabis, and energy. They operate in Canada and the United States, and their diverse portfolio makes growth in 2022 more likely. 

Tilray (NASDAQ - TLRY)

Stock Exchange: NASDAQ

Cost per Stock: $5.98 USD

Growth in the Last Year: - $1.41 (-19.08%)

Lifetime Growth: - $23.79 (-79.91%)

Date Added to Exchange: July 2018

This Canadian cannabis company merged recently with the company Aphria in 2021, making them the largest marijuana producer in the country based on Pro-forma sales. They are a leader in cannabis research, cultivation, processing, and distribution, with aspirations of going global as cannabis continues to validate its legitimacy as a market. They have planned to reach $4 billion in revenue by 2024. If they follow through with their plan, 2022 will be just the start of a long path of financial success. 

Jushi Holdings (OTCMKTS - JUSHF)

Stock Exchange: OTM Market Group

Cost per Stock: $4.15 USD

Growth in the Last Year: $0.010 (0.24%)

Lifetime Growth: $1.81 (77.35%)

Date Added to Exchange: June 2019

Jushi Holdings is another multi-state operator set up for success in 2022. They target limited-license markets (primarily Pennsylvania, Illinois, and Massachusetts), which means they have a large percentage of the regions they supply. The last year was difficult for the cannabis industry, and they managed to maintain their stock valuation, which gives extra promise for 2022 performance.

Cresco Labs (OTCMKTS - CRLBF)

Stock Exchange: OTC Market Group

Cost per Stock: $6.88 USD

Growth in the Last Year: $0.13 (1.93%)

Lifetime Growth: $1.88 (37.60%)

Date Added to Exchange: December 2018

Cresco Labs is a multi-state operator that, like Jushi Holdings, targets limited-license markets. They have 45 dispensaries across the United States, primarily in Illinois, Ohio, Massachusetts, and Florida. These markets have Cresco Labs projected to make impactful growth over the next year. They have large wholesale operations on a large level that also indicates momentum throughout 2022.